Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.34M Buy
42,432
+5,209
+14% +$282K 0.39% 70
2025
Q4
$1.83M Sell
37,223
-1,798
-5% -$83.9K 0.31% 83
2025
Q3
$1.68M Buy
39,021
+1,459
+4% +$57K 0.3% 95
2025
Q2
$1.44M Buy
37,562
+4,464
+13% +$171K 0.27% 97
2025
Q1
$1.28M Buy
33,098
+3,701
+13% +$135K 0.25% 103
2024
Q4
$994K Buy
29,397
+14,288
+95% +$514K 0.2% 119
2024
Q3
$618K Buy
15,109
+2,163
+17% +$88.5K 0.12% 160
2024
Q2
$498K Sell
12,946
-11,555
-47% -$486K 0.11% 187
2024
Q1
$1.05M Buy
24,501
+5,190
+27% +$214K 0.24% 101
2023
Q4
$716K Buy
19,311
+2,009
+12% +$72.1K 0.19% 120
2023
Q3
$627K Sell
17,302
-6,681
-28% -$237K 0.19% 120
2023
Q2
$825K Buy
23,983
+18,133
+310% +$650K 0.14% 161
2023
Q1
$208K Buy
+5,850
New +$205K 0.06% 258

Other funds holding GSK